Early tau PET–GWASs have identified both overlapping and distinct genetic variants compared to amyloid PET, highlighting the importance of integrated analyses to better understand Alzheimer’s disease pathogenesis and develop targeted interventions. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.